Can a simple shake before surgery help ovarian cancer patients?
NCT ID NCT03956095
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether it's possible to give ovarian cancer patients a special nutrition shake for seven days before their surgery. 23 patients took part to see if they would stick with the program. The goal was just to see if the program was doable, not to measure health benefits.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Ensure Surgery Immunonutrition Shake supplements
- What this could lead to
- If successful, this could show that a simple nutrition program before surgery is practical and might help patients recover better.
- What could go wrong
- This is a very small, early feasibility study with only 23 participants. It does not test if the supplements actually improve health outcomes, so results may not lead to any direct benefit.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
23 people
The number who actually took part.
- Started
-
May 2019
- Finished
-
Dec 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Eligible patients will include those who present to MSK for primary surgical management of ovarian cancer.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age ≥ 18 * Scheduled to undergo primary surgical debulking of ovarian, fallopian tube and primary peritoneal cancer * Have a sufficient preoperative window during which the intervention can occur, with the last day of supplementation at least one and no more than two days prior to surgery; scheduling of the procedure should not be delayed due to participation in this investigation Exclusion Criteria: * Have received neoadjuvant chemotherapy * Debulking surgery scheduled less than 8 days from initial visit * Are scheduled for a minimally invasive procedure * Unable to tolerate oral intake or have gastrointestinal issues that would prevent or prohibit oral supplement consumption * Have diabetes mellitus * Have allergies to the Ensure Surgery Immunonutrition Shake supplement * Have galactosemia
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Debulking surgery for ovarian cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Baptist Alliance MCI
Miami, Florida, 33143, United States
-
Memorial Sloan Kettering Basking Ridge (All Protocol Activities)
Basking Ridge, New Jersey, 07920, United States
-
Memorial Sloan Kettering Bergen (All Protocol Activities)
Montvale, New Jersey, 07645, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Memorial Sloan Kettering Commack (All Protocol Activities)
Commack, New York, 11725, United States
-
Memorial Sloan Kettering Monmouth (All Protocol Activities)
Middletown, New Jersey, 07748, United States
-
Memorial Sloan Kettering Nassau (All Protocol Activities)
Uniondale, New York, 11553, United States
-
Memorial Sloan Kettering Westchester (All Protocol Activities)
Harrison, New York, 10604, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can MRI and computer models predict how well cancer drugs reach tumors?
- Can a Patient's own immune cells fight ovarian cancer?
- Ovarian Cancer's spread: scientists probe abdominal fluid for clues
- New PET tracer aims to light up hidden cancer targets
- Can inhaled manganese make ovarian cancer immunotherapy hit harder?
- Can a pill shrink Hard-to-Treat ovarian tumors?